Tags

Tóm tắt CHIP-BCIS3 Trial (do Divaka Perera trình bày) – Ý chính ứng dụng lâm sàng

Randomized trials of patients in cardiogenic shock (CS) have been challenging to conduct. The DanGer Shock (Microaxial Flow Pump in Infarct-Related Cardiogenic Shock) trial was an important study in this space that was successfully concluded after 10 years because of slow recruitment.